Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Mimedx (MDXG) Cost of Revenue (2016 - 2026)

Mimedx's Cost of Revenue history spans 16 years, with the latest figure at $17.4 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 4.89% to $17.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $73.8 million, a 15.99% increase, with the full-year FY2025 number at $73.0 million, up 21.54% from a year prior.
  • Cost of Revenue hit $17.4 million in Q1 2026 for Mimedx, down from $19.1 million in the prior quarter.
  • Over the last five years, Cost of Revenue for MDXG hit a ceiling of $19.1 million in Q4 2025 and a floor of $9.9 million in Q1 2022.
  • Historically, Cost of Revenue has averaged $14.9 million across 5 years, with a median of $14.8 million in 2023.
  • The widest YoY moves for Cost of Revenue: up 102.44% in 2022, down 7.34% in 2022.
  • Tracing MDXG's Cost of Revenue over 5 years: stood at $14.4 million in 2022, then fell by 3.67% to $13.8 million in 2023, then grew by 22.16% to $16.9 million in 2024, then grew by 12.69% to $19.1 million in 2025, then dropped by 8.85% to $17.4 million in 2026.
  • Business Quant data shows Cost of Revenue for MDXG at $17.4 million in Q1 2026, $19.1 million in Q4 2025, and $18.7 million in Q3 2025.